RecallDepth
Class II Ongoing

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

This recall is currently active, issued January 17, 2024. It was issued by Rising Pharma Holding, Inc..

Company
Rising Pharma Holding, Inc.
Recall Initiated
December 29, 2023
Posted
January 17, 2024
Recall Number
D-0222-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
47,976 bottles
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Foreign Tablets/Capsules

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: BPA123098A, Exp. Date 06/2025

More recalls by Rising Pharma Holding, Inc.

View all recalls by this company →

Other recent Class II Drug recalls